Accelerate Your
Trials
Intelligently
Saama automates key clinical development and commercialization processes, with artificial intelligence (AI), Generative AI and advanced-analytics, accelerating your time to market. We offer AI-backed SaaS solutions as well as product based industry services and accelerators.
Proven to Efficiently Advance Research
Study Startup
Budget Share: 10–15%
As-Is:
$5–7.5M
To-Be:
$2–3.5M
Data Management
Budget Share: 10–15%
As-Is:
$5–7.5M
To-Be:
$2–3.5M
Clin Ops & CRA
Budget Share: 20–25%
As-Is:
$10–12.5M
To-Be:
$5–6.75M
Next-Gen RBQM
Budget Share: 5–8%
As-Is:
$2.5–4M
To-Be:
$1.25–2.25M
Medical / Safety
Budget Share: 8–15%
As-Is:
$4–7.5M
To-Be:
$1.5–4M
Biostatistics & Submissions
Budget Share: 8–12%
As-Is:
$4–6M
To-Be:
$1.5–3M
Products and Industry Solutions
Saama accelerates the delivery of therapies to patients through SaaS-based and industry AI and advanced analytics-driven solutions.
The Saama Difference
Saama has over a decade of experience developing and training AI models for life sciences that can be used out-of-the-box. Other companies are just beginning this research. By partnering with Saama, you are ahead of the curve.
Saama has its own AI research lab that consists of some of the world’s best AI researchers globally.
Our AI research lab has spent a decade building, training and evolving AI/ML models specifically for life sciences.
Saama’s AI experts have had work published in over 20 publications globally.
Our AI researchers’ work has been cited globally in various publications.
Our researchers have secured 8 patents for their work.
Saama has worked on many clinical trials, spanning 20+ therapeutic areas.
